Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tissue Transplantation01:24

Tissue Transplantation

271
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
271
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A case of atypical orf virus infection of the hand in an immunocompromised patient.

Skeletal radiology·2026
Same author

Long-term immunogenicity and safety of RZV primary vaccination and revaccination in kidney transplant recipients.

The Journal of infection·2026
Same author

Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Asymptomatic Bacteriuria in Kidney Transplant: Approaches to Screening and Treatment-A National Survey of Canadian Nephrologists.

Clinical transplantation·2026
Same author

Understanding atrial failure: from diagnosis to clinical implications.

Nature reviews. Cardiology·2026
Same author

Comparative Strategies to Overcome Diuretic Resistance in Heart Failure: A Network Meta-Analysis.

JACC. Advances·2026

相关实验视频

Updated: May 9, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.7K

超越完美的捐赠者:一个跨学科的方法来优化捐赠者利用率.

Aditi Venkatraman1, Lebei Pi2, David Belzile3

  • 1Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada.

JACC. Advances
|May 1, 2025
PubMed
概括
此摘要是机器生成的。

实施有针对性的干预措施使捐赠心脏的利用率翻了一番,达到18.5%,并将错过的可行性机会减少到8.6%. 这项研究改善了心脏移植效率,但没有对患者的治疗结果产生负面影响.

关键词:
捐赠者管理 捐赠者管理供体利用率 供体利用率心脏移植心脏移植手术

更多相关视频

Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

731
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

567

相关实验视频

Last Updated: May 9, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.7K
Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

731
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

567

科学领域:

  • 心脏病学 心脏病学
  • 移植手术 移植手术
  • 器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐赠器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器官捐献器

背景情况:

  • 由于当前的接受实践,北美可行的捐赠心脏的大量浪费.
  • 人们对移植心脏的需求越来越大.
  • 需要改进的策略来最大限度地利用捐赠心脏.

研究的目的:

  • 将捐赠人心脏利用率提高到20%的目标.
  • 将错过的可活性捐赠心脏机会减少到≤10%.
  • 评估干预措施对初级移植功能障碍的影响.

主要方法:

  • 预期单中心研究 (2021-2023) 分析捐赠心脏供应.
  • 根据特定的捐赠者标准 (例如,LVEF,年龄,缺血时间) 定义了错过的可行的机会.
  • 实施的干预措施:实时利用仪表板,国际演讲系列和捐助者报告卡.

主要成果:

  • 供体心脏利用率从12.4% (干预前) 增加到18.5% (干预后) (P=0.038).
  • 错过的可行的机会显著下降,从19.3%降至8.6% (P<0.001).
  • 干预后观察到一种减少严重初级移植功能障碍的趋势 (26%对12%,P=0.121).

结论:

  • 跨学科,多方面的干预措施有效地使捐赠心脏利用率翻了一番.
  • 实现了错失可行的机会的显著减少.
  • 短期心脏移植接受者的结果没有受到干预的影响.